aiexpert
Home / News / Brief
Funding · Aug 11, 2026, 02:02 PM · 3 sources

Intel raises $19.7B in equity offering to fund foundry, 14A capacity build

Intel priced a $20 billion common stock offering at $95 per share, netting approximately $19.7 billion after underwriting costs. The offering, which closes August 12, saw $100 billion in investor demand, according to Bloomberg. Underwriters hold a 30-day option to purchase an additional $2.25 billion in stock, potentially bringing total proceeds to ~$23 billion.

The capital raise comes as Intel's valuation has surged 175% in 2026 and quintupled over the past year, lifted by AI infrastructure buildout and a U.S. government 10% equity stake aimed at strengthening domestic chip manufacturing. Intel intends to deploy proceeds toward general corporate purposes including capital expenditures and working capital, with 2026 capex projected to exceed $20 billion.

Intel must compete against TSMC and Samsung, which each spend tens of billions annually on advanced fabs. The company is ramping Arizona Fab 52 and adjacent Fab 62, while Ohio fab construction is expected to cost over $100 billion when complete. Intel 14A, the company's next-gen process, enters mass production in 2028 and requires substantial upfront investment.

For architects: Intel's capital push directly addresses foundry capacity constraints. The raise signals confidence in securing external customers—a prerequisite for competing in the foundry market. Watch for announcements of design wins and volume commitments from major chipmakers; capacity without customers doesn't translate to revenue.

Sources

Everything this brief rests on
  1. 01 Primary source tomshardware.com
  2. 02 cnbc.com cnbc.com “Intel said the offering, set to close on August 12, is expected to raise net proceeds of $19.7 billion, after deducting underwriting discounts and commissions and estimated offering expenses.”
  3. 03 intc.com intc.com “The offering is expected to close on August 12, 2026. The net proceeds from the offering will be approximately $19.7 billion (assuming the underwriters do not exercise their option to purchase additional shares).”